ered by LPS. Conclusions: These results suggest that both natural compounds were able to differently affect several functions of LPS-stressed keratinocytes suggesting their potential role for the prevention of acne vulgaris, without adverse effects.
ment involves androgen-mediated stimulation of sebaceous gland activity, follicular hyperkeratinization and colonization of Propionibacterium acnes . Acne is currently treated by the use of local applications, oral antibiotics, retinoids and hormonal therapies: nonetheless, increasing interest is focused on natural plant derivatives [5] . Some natural compounds (e.g., mixtures of phenolic compounds) have recently come under investigation as promising drugs for new dermal cosmetics that possess the ability to maintain skin cell renewal (elastin and collagen stimulation) [6] . Mixed formulations (kaempferol and either erythromycin or clindamycin; quercetin and either erythromycin or clindamycin) synergically inhibit antibiotic-resistant P. acnes growth [7] . The European Pharmacopeia defines white willow bark (WWB) as the whole or fragmented dried bark of young branches or dried pieces of current year twigs from various species of the genus Salix [8] . WWB has been used as a traditional medicine for the treatment of fever, pain, and inflammation [9] . Salicin, the major constituent of WWB extract, is metabolized to salicylic acid in vivo and shows antiinflammatory effects; moreover, other ingredients in the extracts include other salicylates as well as polyphenols and flavonoids, which could play prominent roles in the therapeutic efficacy [10] . WWB suppresses inflammatory molecules and reduces oxidative stress in human endothelial cells [11, 12] . In vitro and in vivo studies evidenced that the anti-inflammatory activity of WWB is associated with the downregulation of the inflammatory mediators TNF-α and NF-κB [13] . In 2010, a paper by Gopaul et al. [14] described the ability of salicin to reduce the visible signs of skin aging when applied topically, thus showing anti-aging capabilities.
Among natural compounds involved in the regulation of skin homeostasis, 1,2-alkanediols display several properties (high water solubility and effectiveness as a solvent) that allow their use as moisturizing compounds in the dermal cosmetic field [15] [16] [17] . Indeed, their bacteriostatic and fungistatic activity decreased the amount of conventional preservatives inside cosmetic formulations. Generally, the antimicrobial effect of 1,2-alkanediols increases with the length of their carbon chain, with 1,2-decanediol (DD) having a minimal inhibitory concentration of <1%, which is 10-fold lower than that of 1,2-octanediol [18] . A recent study reported the effects of five 1,2-alkanediols on skin irritation potentials [19] that represent an important factor for determining the usefulness of 1,2-alkanediols.
Here we tested the effects of WWB and DD, used alone or in combination, on human adult keratinocytes (HaCaT) stressed by lipopolysaccharides (LPS). Moreover, we investigated a possible role of DD not only as a moisturizing agent, but also as bioactive molecule on epidermal layers. 
Materials and Methods

Drugs
LPS from Escherichia coli were purchased from Sigma-Aldrich. DD is a diol monomer, solid and soluble only in cosmetic esters, and acts as an anti-acne agent and antiperspirant (Symrise, Holzminden, Germany). WWB is an extract of the white bark of Salix alba that is standardized for its salicin content (Euromed, Barcelona, Spain). DD and WWB were prepared in 0.001% DMSO (see Table 1 for concentrations).
Cell Cultures
A human adult keratinocyte cell line (HaCaT) was obtained from Cell Line Services (CLS Cell Lines Service, Germany). HaCaT were grown in Dulbecco modified Eagle medium (DMEM) with 10% fetal calf serum and 1% antibiotic/antimycotic (Invitrogen, Grand Island, NY, USA).
Cell Viability
HaCaT were seeded in 96-well plates (5,000 cells/well). Cells were treated as indicated in 
Enzyme-Linked Immunosorbent Assay
Proinflammatory cytokines (IL-1α, IL-6 and IL-8), growth factors (VEGF, EGF, IGF-I), metabolic markers (keratin 16, KRT-16) and transcriptional factors (FOXO-I) were quantified in cell lysates or medium by enzyme-linked immunosorbent assay (ELISA) using commercially available kits (Sigma ELISA kit, Invitrogen ELISA kit). Briefly, 100 μL of medium or cell lysate were incubated into an antibody-coated 96-well plate at room temperature for 2.5 h. The wells were washed 4 times with wash buffer solution. Then 100 μL of primary anti-human antibody was added, and the samples were again incubated for 1 h at room temperature. The plate was washed 4 times, 100 μL of streptavidin-peroxidase conjugate was applied for 1 h at room temperature. After a final washing, 100 μL tetramethylbenzidine substrate was added and allowed to develop for 30 min in the dark at room temperature. After stopping the reaction with 50 μL stop solution containing citric acid 2.0 mmol/L, absorbance was read at 450 nm with an F5 FilterMax microplate reader 550 (Molecular Devices, USA). Sample concentration was calculated from the standard curve.
Cytosolic and Nuclear Protein Extraction for FOXO-I Quantification
HaCaT were grown to 80% confluence. Afterwards, cells were scraped using fresh PBS, collected into an appropriate conical tube and centrifuged (5 min at 450 g ). Then the supernatant was discarded, and 1 mL of lysis buffer (10 m M Tris HCl, pH 7. 
Scratch Wound Healing
HaCaT were seeded in 24 multiwell plates and cultured to confluence. A scratch was made in the confluent monolayer with a plastic disposable pipette tip (10 μL). Debris was removed from the culture by gently washing with sterile PBS. Hereafter, HaCaT were cultured in DMEM 10% and treated with 10 μg/mL LPS, DD, WWB alone or in association for 24 h. Experiments were performed using a Nikon T-E microscope (4× objective). Cells were kept at 37 ° C and 5% CO 2 for all experiments. Photos were taken every 4 h using Metamorph software. Cell migration was measured with ImageJ software (Rasband W.S., ImageJ, US National Institutes of Health, Bethesda, MD, USA). At least 3 fields for each condition were analyzed in each independent experiment.
Statistical Analysis
Statistical significance of all experiments was evaluated by GraphPad software (Synergy Software, USA). The Dunnet multicomparison test was chosen because 5 biological replicates were done for each condition in each experiment, and they were not normally distributed. Five technical replicates were performed for each experimental condition; 3 biological replicates were performed for each experimental condition.
Results with p values <0.05 were considered statistically significant. The lowest concentrations of WWB and DD differently affect EGF, IGF-I and KRT-16 production and FOXO-I translocation. * p < 0.05. CTRL, control. A HaCaT were stimulated with 10 μg/mL LPS alone ( i ) or in association with the lowest concentrations (C) of WWB and DD ( ii ). Supernatant was collected after 24 h, and EGF secretion was quantified with ELISA. 10 μg/mL LPS increased EGF production ( i ). WWB and DD (alone or in association) significantly reduced EGF production increased by LPS treatment (24 h) ( ii ). B HaCaT were stimulated with 10 μg/mL LPS used alone ( i ) or in association with the lowest concentrations (C) of WWB and DD ( ii ). Supernatant was collected after 24 h, and IGF-I secretion was quantified with ELISA. 10 μg/mL LPS increased IGF-I production after 24 h of treatment ( i ). WWB/DD complex significantly reduced IGF-I production affected by LPS (24 h) ( ii ). C HaCaT were stimulated with 10 μg/mL LPS used alone ( i ) or in association with the lowest concentrations (C) of WWB and DD ( ii ). Cytosolic extract was collected after 24 h, and KRT-16 secretion was quantified with ELISA. 10 μg/mL LPS slightly but not significantly increased KRT-16 production ( i ). WWB or DD used alone or in combination did not significantly modify KRT-16 production (24 h) ( ii ). D HaCaT were stimulated with 10 μg/mL LPS used alone ( i ) or in association with the lowest concentrations (C) of WWB and DD ( ii ). After 24 h cytosolic and nuclear FOXO-I extracts were obtained and quantified with ELISA. 10 μg/mL LPS increased the cytosolic/nuclear (cyt/nu) ratio of FOXO-I ( i ). Both WWB and DD used alone or in association (lowest dose) significantly reduced the FOXO-I ratio (24 h) ( ii ). DD dose C: 13 μg/mL; WWB dose C: 130 μg/mL; WWB/DD dose C: 13 μg/mL + 130 μg/ mL. 
Results
WWB and DD Affect Cell Viability of Human Adult Keratinocytes Treated with LPS
In order to set a suitable pattern of LPS concentrations to be tested, we performed a preliminary dose-response curve of HaCaT viability. Lower concentrations of LPS (up to 10 μg/mL for 24 h) did not affect HaCaT number, while a higher dose (25 μg/mL for 24 h) significantly reduced cell viability ( Fig. 1 A) . Based on these results, we first evaluated the effect of WWB and DD (separately or as WWB/DD complex) on cells treated with 10 μg/mL LPS (ineffective dose). High concentrations of DD significantly affected cell viability, while lower doses were ineffective ( Fig. 1 B) . WWB (B concentration) significantly affected cell viability ( Fig. 1 C) . The association of both compounds (WWB/DD complex) significantly reduced cell viability when added both at higher doses in HaCaT treated with 10 μg/mL LPS ( Fig. 1 F) . Both compounds failed to prevent the cytotoxicity induced by 25 μg/ml LPS both separately ( Fig. 1 D, E ) and in complex ( Fig. 1 G) . For the following tests we chose the lowest, noncytotoxic concentrations of the natural compounds, and we tested their effects on 10 μg/mL LPS.
Release of EGF, IGF-I, and KRT-16
10 μg/mL LPS promoted a significant EGF release by HaCaT (24 h) ( Fig. 2 Ai) . DD and WWB, both separately and in complex, significantly prevented LPS-induced EGF release ( Fig. 2 Aii) . The same trend was observed on IGF-I release ( Fig. 2 Bi, ii) . Finally, the treatment with 10 μg/mL LPS slightly, but not significantly, increased KRT-16 production ( Fig. 2 Ci) , an effect slightly prevented by DD ( Fig. 2 Cii) .
FOXO-I Distribution
Incubation with 10 μg/mL LPS (24 h) drastically enhanced cytosolic expression of FOXO-I ( Fig. 2 Di) ; this effect was prevented by incubation with DD and WWB, both separately or in combination ( Fig. 2 Dii) .
Modulation of Wound Closure and Anti-Inflammatory Role of WWB and DD
To evaluate the role of both compounds in the wound healing rate of HaCaT, we first examined their ability to modulate cell motility employing an established in vitro scratch wound healing assay. Wound closure was evaluated by observing the repopulated area between the wound margins at different time intervals (0-24 h) after the lesion. The wound monitoring showed that untreated cells (DMEM 10%) followed the physiological healing process, reaching approximately 65% of closure at 24 h after injury ( Fig. 3 A, Bi) . 10 μg/mL LPS (24 h) drastically reduced the wound closure percentage, reaching approximately 35%. This effect was prevented by both DD and WWB applied separately ( Fig. 3 A, Bii) . Application of 10 μg/mL LPS reduced VEGF production in scratched keratinocytes ( Fig. 3 Ci) . DD and WWB/DD complex prevented the LPS effect, while WWB was found to be ineffective ( Fig. 3 Cii) . Skin wounding and inflammatory responses involve cytokines that exert inhibitory activity on human keratinocyte growth. We investigated the effects of DD and WWB both separately and in association on cytokine production (IL-1 α, IL-6, and IL-8) by HaCaT upon treatment with LPS.
Incubation with 10 μg/mL LPS (24 h) promoted the release of IL-8, IL-1α, and IL-6 ( Fig. 3 Di, Ei, Fi) . The lowest doses of DD and WWB, separately or in combination, did not prevent IL-1α production ( Fig. 3 Eii) ; conversely, WWB and WWB/DD were significantly effective on IL-6 and IL-8 release, while DD induced a nonsignificant protective activity ( Fig. 3 Dii, Fii).
Discussion
Acne is a multifactorial disease based on an alteration in the pattern of keratinization within the pilosebaceous follicles resulting in comedo formation, an increase in sebum production which is influenced by androgens, the proliferation of P. acnes , and the development of perifollicular inflammation [20, 21] . New commercially available formulations and drugs for skin treatment are increasingly introduced. Evidence suggests a potential beneficial activity of plant-derived phenolic compounds obtained either by the diet or through skin application; indeed, they can alleviate symptoms and inhibit the development of various skin disorders. Recently, a novel face compact cream containing a new patented formulation (including both WWB extract and DD) was developed to provide acne patients with cosmetic camouflage for their lesions and to have beneficial effects on the multifactorial components of the disease [22] . Here we tested the role of both compounds on adult keratinocytes stressed with LPS. Both compounds (used alone or in combination) counteracted LPS effects, reducing growth factor and cytokine production. They reduced EGF expression altered by the treatment with LPS. This is interesting because several studies report the alteration of EGF signaling during acne associated with the use of anticancer agents (e.g., EGF receptor inhibitors). Acneiform eruptions are a common 17 adverse reaction to EGF receptor inhibition and can be treated with traditional acne therapy [23] . Similarly, WWB/DD complex significantly prevented IGF-I production induced by LPS. During puberty, IGF-I signaling may have a causal role in the pathogenesis of acne by influencing adrenal and gonadal androgen metabolism that was reported to be an inducer of sebum production through sterol response element-binding proteins [24, 25] . Recently, the involvement of IGF-I, but not androgens, has been suggested in acne pathogenesis [26] . A relevant IGF-I-dependent mechanism that increases androgen receptor signaling involves the metabolic transcription factor FOXO-I. FOXO-I is proposed to be the key to understand the link between genetic and environmental factors in acne. Nuclear FOXO-I functions as an androgen receptor cosuppressor which regulates the activity of most important target genes involved in the pathogenesis of acne [27] . All growth factors or acneigenic stimuli mimicking growth factor signaling might lead to the reduction of the nuclear content of FOXO-I. In the present study, we observed that WWB and DD, used separately or in combination, significantly decrease the FOXO-I cytosolic/nuclear ratio. Both WWB and DD slightly but not significantly prevented KRT-16 expression after LPS treatment. KRT-16, as well as KRT-6 and KRT-17, is considered a stress KRT chronically expressed in human premalignant hyperproliferative epithelium [28] . Finally, we tested the role of natural compounds in the modulation of keratinocyte migration and in the production of proinflammatory cytokines. Li et al. [29] reported the ability of LPS to reduce keratinocyte migration in a diabetes-like microenvironment. Here we observed that both compounds markedly promoted HaCaT migration and enhanced artificial wound closure compromised by LPS treatment, an effect related to their ability to sustain VEGF production. Cellfree extracts of P. acnes significantly stimulate secretion of interleukins (IL-8 and IL-6) in SZ95 sebocytes [30] and promote IL-8 secretion by interacting with Toll-like receptor 2 [31] . IL-6 is a pleiotropic cytokine that plays a pivotal role in host defense, immune response regulation, hematopoiesis, and inflammation [32] . Single-nucleotide polymorphisms in the IL-6 gene have been identified and associated with several diseases [33, 34] . However, there are relatively few studies on IL-6 gene polymorphism in acne patients. It has recently been reported that the IL-6 and IL-1α gene promoter polymorphisms are associated with the pathogenesis of acne vulgaris [35] . IL-1α has been widely studied in inflammation and is considered to affect the pathogenesis of acne [36] ; it also contributes to paracrine signaling between keratinocytes and fibroblasts during wound healing. WWB and DD differently affect cytokine production. Both compounds failed to counteract IL-1α release increased by LPS treatment. Conversely, WWB alone or WWB/DD complex significantly reduced IL-6 and IL-8 release, while only a slight effect could be observed upon stimulation with DD alone.
In conclusion, taken together, our results show the ability of both natural compounds to affect different functions of LPS-stressed keratinocytes. The percentage of wound closure is shown as means ± SEM of 3 independent experiments. C HaCaT were scratched and stimulated with 10 μg/mL LPS used alone or in the presence of WWB and DD (alone or in complex, both at the lowest concentration). Supernatant was collected 24 h after scraping, and VEGF production was quantified with ELISA. 10 μg/mL LPS significantly reduced VEGF production ( i ). DD alone or in complex with WWB complex significantly prevented the VEGF reduction ( ii ). D HaCaT were stimulated with 10 μg/mL LPS used alone or in the presence of WWB and DD (alone or in complex, both at the lowest concentration). Supernatant was collected after 24 h, and IL-8 secretion was quantified with ELISA. 10 μg/mL LPS significantly increased IL-8 production ( i ). WWB alone or WWB/DD complex significantly prevented this effect ( ii ). E HaCaT were stimulated with 10 μg/mL LPS used alone ( i ) or in the presence ( ii ) of WWB and DD (used alone or in complex, both at the lowest concentration). Supernatant was collected after 24 h, and IL-1α secretion was quantified with ELISA. 10 μg/mL LPS significantly increased Il-1α release ( i ). DD and WWB alone or in association did not modify this effect ( ii ). F HaCaT were stimulated with 10 μg/mL LPS used alone ( i ) or in association ( ii ) with WWB and DD (alone or in complex, both at the lowest concentration). Supernatant was collected after 24 h, and IL-6 secretion was quantified with ELISA. 10 μg/mL LPS significantly increased IL-6 release ( i ). WWB alone or in association with DD significantly prevented this effect ( ii ). DD dose C: 13 μg/mL; WWB dose C: 130 μg/mL; DD/WWB dose C: 13 μg/mL + 130 μg/mL.
